BPER Banca SpA (BIT:BPE)

ASLAN Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7,585	7,888	10,086	13,997	1,306	849.1
Investment Securities	6,665	13,486	15,336	16,278	14,046	12,096
Trading Asset Securities	1,424	1,440	1,903	2,860	677.9	449.29
Total Investments	8,089	14,925	17,239	19,138	14,724	12,545
Gross Loans	119,093	107,654	103,576	108,653	96,762	68,336
Allowance for Loan Losses	-	-1,634	-1,523	-1,884	-2,111	-1,772
Net Loans	119,093	106,021	102,052	106,769	94,651	66,564
Property, Plant & Equipment	2,454	2,066	1,963	2,094	1,647	1,093
Goodwill	170.02	170.02	170.02	204.39	204.39	434.76
Other Intangible Assets	542.65	540.75	478.96	359.11	254.81	267.97
Investments in Real Estate	-	436.42	494.03	452.35	297.51	272.36
Accrued Interest Receivable	-	13.86	18.44	18.55	11.38	14.52
Other Receivables	309.38	5,422	5,985	3,742	1,168	716.94
Restricted Cash	-	1,014	1,037	1,348	20,310	8,353
Other Current Assets	51.6	499.04	302.51	1,534	199.83	248.02
Long-Term Deferred Tax Assets	1,151	1,384	1,834	2,352	1,374	1,585
Other Long-Term Assets	5,082	197.04	455.38	278.6	184.27	108.91
Total Assets	144,528	140,591	142,128	152,303	136,348	93,062
Accounts Payable	-	366.87	394	444.64	290.19	247.13
Accrued Expenses	-	1,041	985.68	809.32	540.61	264.31
Interest Bearing Deposits	107,426	3,073	4,543	2,696	1,192	1,064
Non-Interest Bearing Deposits	-	93,869	94,751	102,895	92,054	55,166
Total Deposits	107,426	96,943	99,294	105,590	93,246	56,230
Short-Term Borrowings	321.41	5,889	6,636	4,318	6,533	3,525
Current Portion of Leases	-	74.93	70.51	80.43	67.31	54.31
Current Income Taxes Payable	66.62	15.18	10.64	8.17	9.6	4.8
Other Current Liabilities	5.33	1,329	411.57	1,800	1,399	846.15
Long-Term Debt	17,333	20,340	20,732	27,305	25,167	23,849
Long-Term Leases	-	338.15	257.94	288.69	263.05	203.28
Pension & Post-Retirement Benefits	221.83	243.1	272.12	294.81	352.47	298.2
Long-Term Deferred Tax Liabilities	66.22	57.11	56.77	63.39	58.9	77.52
Other Long-Term Liabilities	7,454	2,391	3,442	3,179	1,560	1,128
Total Liabilities	132,894	129,027	132,563	144,182	129,489	86,728
Common Stock	2,122	2,122	2,104	2,104	2,100	2,100
Additional Paid-In Capital	1,251	1,245	1,237	1,237	1,240	1,241
Retained Earnings	903.47	6,017	5,056	3,785	2,440	2,019
Treasury Stock	-4.4	-32.04	-2.25	-5.68	-9.55	-7.26
Comprehensive Income & Other	7,162	2,002	971.61	818.88	925.2	846.36
Total Common Equity	11,434	11,354	9,366	7,940	6,696	6,200
Minority Interest	199.85	210.41	199.33	180.36	162.5	133.98
Shareholders' Equity	11,634	11,564	9,565	8,121	6,859	6,334
Total Liabilities & Equity	144,528	140,591	142,128	152,303	136,348	93,062
Total Debt	17,654	26,642	27,696	31,992	32,031	27,631
Net Cash (Debt)	-8,645	-16,935	-15,328	-14,537	-29,509	-26,121
Net Cash Per Share	-5.97	-11.69	-10.57	-10.04	-20.38	-36.55
Filing Date Shares Outstanding	1,417	1,416	1,415	1,414	1,411	1,413
Total Common Shares Outstanding	1,417	1,416	1,415	1,414	1,411	1,413
Book Value Per Share	8.07	8.02	6.62	5.61	4.75	4.39
Tangible Book Value	10,721	10,643	8,717	7,377	6,237	5,497
Tangible Book Value Per Share	7.57	7.52	6.16	5.22	4.42	3.89

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.